These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2387549)

  • 1. [Therapy with antithrombin III in burned children--pilot study].
    Del Principe D; Pietrantoni R; Menichelli A; Siviero MC; Luzi F; Colucci C; Orsini D
    Haematologica; 1990; 75 Suppl 2():33-40. PubMed ID: 2387549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary study for the evaluation of the feasibility of a multicenter clinical trial for the evaluation of the therapeutic efficacy of an antithrombin III concentration (Immuno) in the intravascular coagulation syndrome].
    Palareti G; Legnani C; Ludovici S; Maccaferri M
    Haematologica; 1990; 75 Suppl 2():21-32. PubMed ID: 2201605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disseminated intravascular coagulation in children. Therapeutic problems].
    Fiori GM; Murgia G; Targhetta R; Putzolu G; Biddau P
    Pediatr Med Chir; 1989; 11(5):491-4. PubMed ID: 2698466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of antithrombin III in shock and DIC: a randomized study.
    Blauhut B; Kramar H; Vinazzer H; Bergmann H
    Thromb Res; 1985 Jul; 39(1):81-9. PubMed ID: 4035650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.
    Jespersen J; Rasmussen NR; Toftgaard C
    Thromb Res; 1982 Jun; 26(6):457-62. PubMed ID: 7112521
    [No Abstract]   [Full Text] [Related]  

  • 13. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin therapy in bacterial shock and acute kidney failure].
    Dobrovol'skiĭ VI; Makatsariia AD
    Sov Med; 1984; (6):90-3. PubMed ID: 6463755
    [No Abstract]   [Full Text] [Related]  

  • 15. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency--a feasibility pilot study.
    Kreuz WD; Schneider W; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S187-91. PubMed ID: 10650867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin (AT) substitution: sense or nonsense?
    Köhler M
    Anaesthesia; 1998 May; 53 Suppl 2():52-4. PubMed ID: 9659067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 20. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
    Iba T; Thachil J
    Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.